COVID-19 Impact on Global Hemoglobinopathy Drugs Market Size, Status and Forecast 2020-2026
![](/report_cover/6975/covid-19-impact-on-global-hemoglobinopathy-drugs-market-size-status-n-forecast-2020-2026_en.gif)
This report focuses on the global Hemoglobinopathy Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hemoglobinopathy Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
The key players covered in this study
- Novartis
- AstraZeneca
- Bluebird
- Bristol-Myers Squibb
- Emmaus Medical
- Acceleron Pharma
- HemaQuest Pharmaceuticals
- Eli Lilly and Company
- Celgene
- Hydroxyurea
- Glutamine
- Zynteglo
- Other
- Sickle Cell Diseases
- Thalassemia
- North America
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
- To analyze global Hemoglobinopathy Drugs status, future forecast, growth opportunity, key market and key players.
- To present the Hemoglobinopathy Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by type, market and key regions.
- History Year: 2015-2019
- Base Year: 2019
- Estimated Year: 2020
- Forecast Year 2020 to 2026
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hemoglobinopathy Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Hemoglobinopathy Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Hydroxyurea
1.4.3 Glutamine
1.4.4 Zynteglo
1.4.5 Other
1.5 Market by Application
1.5.1 Global Hemoglobinopathy Drugs Market Share by Application: 2020 VS 2026
1.5.2 Sickle Cell Diseases
1.5.3 Thalassemia
1.6 Coronavirus Disease 2019 (Covid-19): Hemoglobinopathy Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the Hemoglobinopathy Drugs Industry
1.6.1.1 Hemoglobinopathy Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Hemoglobinopathy Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Hemoglobinopathy Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Hemoglobinopathy Drugs Market Perspective (2015-2026)
2.2 Hemoglobinopathy Drugs Growth Trends by Regions
2.2.1 Hemoglobinopathy Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hemoglobinopathy Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Hemoglobinopathy Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hemoglobinopathy Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Hemoglobinopathy Drugs Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Hemoglobinopathy Drugs Players by Market Size
3.1.1 Global Top Hemoglobinopathy Drugs Players by Revenue (2015-2020)
3.1.2 Global Hemoglobinopathy Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Hemoglobinopathy Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hemoglobinopathy Drugs Market Concentration Ratio
3.2.1 Global Hemoglobinopathy Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hemoglobinopathy Drugs Revenue in 2019
3.3 Hemoglobinopathy Drugs Key Players Head office and Area Served
3.4 Key Players Hemoglobinopathy Drugs Product Solution and Service
3.5 Date of Enter into Hemoglobinopathy Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Hemoglobinopathy Drugs Historic Market Size by Type (2015-2020)
4.2 Global Hemoglobinopathy Drugs Forecasted Market Size by Type (2021-2026)
5 HEMOGLOBINOPATHY DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Hemoglobinopathy Drugs Market Size by Application (2015-2020)
5.2 Global Hemoglobinopathy Drugs Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Hemoglobinopathy Drugs Market Size (2015-2020)
6.2 Hemoglobinopathy Drugs Key Players in North America (2019-2020)
6.3 North America Hemoglobinopathy Drugs Market Size by Type (2015-2020)
6.4 North America Hemoglobinopathy Drugs Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Hemoglobinopathy Drugs Market Size (2015-2020)
7.2 Hemoglobinopathy Drugs Key Players in Europe (2019-2020)
7.3 Europe Hemoglobinopathy Drugs Market Size by Type (2015-2020)
7.4 Europe Hemoglobinopathy Drugs Market Size by Application (2015-2020)
8 CHINA
8.1 China Hemoglobinopathy Drugs Market Size (2015-2020)
8.2 Hemoglobinopathy Drugs Key Players in China (2019-2020)
8.3 China Hemoglobinopathy Drugs Market Size by Type (2015-2020)
8.4 China Hemoglobinopathy Drugs Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Hemoglobinopathy Drugs Market Size (2015-2020)
9.2 Hemoglobinopathy Drugs Key Players in Japan (2019-2020)
9.3 Japan Hemoglobinopathy Drugs Market Size by Type (2015-2020)
9.4 Japan Hemoglobinopathy Drugs Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Hemoglobinopathy Drugs Market Size (2015-2020)
10.2 Hemoglobinopathy Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hemoglobinopathy Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Hemoglobinopathy Drugs Market Size by Application (2015-2020)
11 INDIA
11.1 India Hemoglobinopathy Drugs Market Size (2015-2020)
11.2 Hemoglobinopathy Drugs Key Players in India (2019-2020)
11.3 India Hemoglobinopathy Drugs Market Size by Type (2015-2020)
11.4 India Hemoglobinopathy Drugs Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Hemoglobinopathy Drugs Market Size (2015-2020)
12.2 Hemoglobinopathy Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Hemoglobinopathy Drugs Market Size by Type (2015-2020)
12.4 Central & South America Hemoglobinopathy Drugs Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Novartis
13.1.1 Novartis Company Details
13.1.2 Novartis Business Overview and Its Total Revenue
13.1.3 Novartis Hemoglobinopathy Drugs Introduction
13.1.4 Novartis Revenue in Hemoglobinopathy Drugs Business (2015-2020))
13.1.5 Novartis Recent Development
13.2 AstraZeneca
13.2.1 AstraZeneca Company Details
13.2.2 AstraZeneca Business Overview and Its Total Revenue
13.2.3 AstraZeneca Hemoglobinopathy Drugs Introduction
13.2.4 AstraZeneca Revenue in Hemoglobinopathy Drugs Business (2015-2020)
13.2.5 AstraZeneca Recent Development
13.3 Bluebird
13.3.1 Bluebird Company Details
13.3.2 Bluebird Business Overview and Its Total Revenue
13.3.3 Bluebird Hemoglobinopathy Drugs Introduction
13.3.4 Bluebird Revenue in Hemoglobinopathy Drugs Business (2015-2020)
13.3.5 Bluebird Recent Development
13.4 Bristol-Myers Squibb
13.4.1 Bristol-Myers Squibb Company Details
13.4.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
13.4.3 Bristol-Myers Squibb Hemoglobinopathy Drugs Introduction
13.4.4 Bristol-Myers Squibb Revenue in Hemoglobinopathy Drugs Business (2015-2020)
13.4.5 Bristol-Myers Squibb Recent Development
13.5 Emmaus Medical
13.5.1 Emmaus Medical Company Details
13.5.2 Emmaus Medical Business Overview and Its Total Revenue
13.5.3 Emmaus Medical Hemoglobinopathy Drugs Introduction
13.5.4 Emmaus Medical Revenue in Hemoglobinopathy Drugs Business (2015-2020)
13.5.5 Emmaus Medical Recent Development
13.6 Acceleron Pharma
13.6.1 Acceleron Pharma Company Details
13.6.2 Acceleron Pharma Business Overview and Its Total Revenue
13.6.3 Acceleron Pharma Hemoglobinopathy Drugs Introduction
13.6.4 Acceleron Pharma Revenue in Hemoglobinopathy Drugs Business (2015-2020)
13.6.5 Acceleron Pharma Recent Development
13.7 HemaQuest Pharmaceuticals
13.7.1 HemaQuest Pharmaceuticals Company Details
13.7.2 HemaQuest Pharmaceuticals Business Overview and Its Total Revenue
13.7.3 HemaQuest Pharmaceuticals Hemoglobinopathy Drugs Introduction
13.7.4 HemaQuest Pharmaceuticals Revenue in Hemoglobinopathy Drugs Business (2015-2020)
13.7.5 HemaQuest Pharmaceuticals Recent Development
13.8 Eli Lilly and Company
13.8.1 Eli Lilly and Company Company Details
13.8.2 Eli Lilly and Company Business Overview and Its Total Revenue
13.8.3 Eli Lilly and Company Hemoglobinopathy Drugs Introduction
13.8.4 Eli Lilly and Company Revenue in Hemoglobinopathy Drugs Business (2015-2020)
13.8.5 Eli Lilly and Company Recent Development
13.9 Celgene
13.9.1 Celgene Company Details
13.9.2 Celgene Business Overview and Its Total Revenue
13.9.3 Celgene Hemoglobinopathy Drugs Introduction
13.9.4 Celgene Revenue in Hemoglobinopathy Drugs Business (2015-2020)
13.9.5 Celgene Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hemoglobinopathy Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Hemoglobinopathy Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Hydroxyurea
1.4.3 Glutamine
1.4.4 Zynteglo
1.4.5 Other
1.5 Market by Application
1.5.1 Global Hemoglobinopathy Drugs Market Share by Application: 2020 VS 2026
1.5.2 Sickle Cell Diseases
1.5.3 Thalassemia
1.6 Coronavirus Disease 2019 (Covid-19): Hemoglobinopathy Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the Hemoglobinopathy Drugs Industry
1.6.1.1 Hemoglobinopathy Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Hemoglobinopathy Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Hemoglobinopathy Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Hemoglobinopathy Drugs Market Perspective (2015-2026)
2.2 Hemoglobinopathy Drugs Growth Trends by Regions
2.2.1 Hemoglobinopathy Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hemoglobinopathy Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Hemoglobinopathy Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hemoglobinopathy Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Hemoglobinopathy Drugs Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Hemoglobinopathy Drugs Players by Market Size
3.1.1 Global Top Hemoglobinopathy Drugs Players by Revenue (2015-2020)
3.1.2 Global Hemoglobinopathy Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Hemoglobinopathy Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hemoglobinopathy Drugs Market Concentration Ratio
3.2.1 Global Hemoglobinopathy Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hemoglobinopathy Drugs Revenue in 2019
3.3 Hemoglobinopathy Drugs Key Players Head office and Area Served
3.4 Key Players Hemoglobinopathy Drugs Product Solution and Service
3.5 Date of Enter into Hemoglobinopathy Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Hemoglobinopathy Drugs Historic Market Size by Type (2015-2020)
4.2 Global Hemoglobinopathy Drugs Forecasted Market Size by Type (2021-2026)
5 HEMOGLOBINOPATHY DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Hemoglobinopathy Drugs Market Size by Application (2015-2020)
5.2 Global Hemoglobinopathy Drugs Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Hemoglobinopathy Drugs Market Size (2015-2020)
6.2 Hemoglobinopathy Drugs Key Players in North America (2019-2020)
6.3 North America Hemoglobinopathy Drugs Market Size by Type (2015-2020)
6.4 North America Hemoglobinopathy Drugs Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Hemoglobinopathy Drugs Market Size (2015-2020)
7.2 Hemoglobinopathy Drugs Key Players in Europe (2019-2020)
7.3 Europe Hemoglobinopathy Drugs Market Size by Type (2015-2020)
7.4 Europe Hemoglobinopathy Drugs Market Size by Application (2015-2020)
8 CHINA
8.1 China Hemoglobinopathy Drugs Market Size (2015-2020)
8.2 Hemoglobinopathy Drugs Key Players in China (2019-2020)
8.3 China Hemoglobinopathy Drugs Market Size by Type (2015-2020)
8.4 China Hemoglobinopathy Drugs Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Hemoglobinopathy Drugs Market Size (2015-2020)
9.2 Hemoglobinopathy Drugs Key Players in Japan (2019-2020)
9.3 Japan Hemoglobinopathy Drugs Market Size by Type (2015-2020)
9.4 Japan Hemoglobinopathy Drugs Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Hemoglobinopathy Drugs Market Size (2015-2020)
10.2 Hemoglobinopathy Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hemoglobinopathy Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Hemoglobinopathy Drugs Market Size by Application (2015-2020)
11 INDIA
11.1 India Hemoglobinopathy Drugs Market Size (2015-2020)
11.2 Hemoglobinopathy Drugs Key Players in India (2019-2020)
11.3 India Hemoglobinopathy Drugs Market Size by Type (2015-2020)
11.4 India Hemoglobinopathy Drugs Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Hemoglobinopathy Drugs Market Size (2015-2020)
12.2 Hemoglobinopathy Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Hemoglobinopathy Drugs Market Size by Type (2015-2020)
12.4 Central & South America Hemoglobinopathy Drugs Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Novartis
13.1.1 Novartis Company Details
13.1.2 Novartis Business Overview and Its Total Revenue
13.1.3 Novartis Hemoglobinopathy Drugs Introduction
13.1.4 Novartis Revenue in Hemoglobinopathy Drugs Business (2015-2020))
13.1.5 Novartis Recent Development
13.2 AstraZeneca
13.2.1 AstraZeneca Company Details
13.2.2 AstraZeneca Business Overview and Its Total Revenue
13.2.3 AstraZeneca Hemoglobinopathy Drugs Introduction
13.2.4 AstraZeneca Revenue in Hemoglobinopathy Drugs Business (2015-2020)
13.2.5 AstraZeneca Recent Development
13.3 Bluebird
13.3.1 Bluebird Company Details
13.3.2 Bluebird Business Overview and Its Total Revenue
13.3.3 Bluebird Hemoglobinopathy Drugs Introduction
13.3.4 Bluebird Revenue in Hemoglobinopathy Drugs Business (2015-2020)
13.3.5 Bluebird Recent Development
13.4 Bristol-Myers Squibb
13.4.1 Bristol-Myers Squibb Company Details
13.4.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
13.4.3 Bristol-Myers Squibb Hemoglobinopathy Drugs Introduction
13.4.4 Bristol-Myers Squibb Revenue in Hemoglobinopathy Drugs Business (2015-2020)
13.4.5 Bristol-Myers Squibb Recent Development
13.5 Emmaus Medical
13.5.1 Emmaus Medical Company Details
13.5.2 Emmaus Medical Business Overview and Its Total Revenue
13.5.3 Emmaus Medical Hemoglobinopathy Drugs Introduction
13.5.4 Emmaus Medical Revenue in Hemoglobinopathy Drugs Business (2015-2020)
13.5.5 Emmaus Medical Recent Development
13.6 Acceleron Pharma
13.6.1 Acceleron Pharma Company Details
13.6.2 Acceleron Pharma Business Overview and Its Total Revenue
13.6.3 Acceleron Pharma Hemoglobinopathy Drugs Introduction
13.6.4 Acceleron Pharma Revenue in Hemoglobinopathy Drugs Business (2015-2020)
13.6.5 Acceleron Pharma Recent Development
13.7 HemaQuest Pharmaceuticals
13.7.1 HemaQuest Pharmaceuticals Company Details
13.7.2 HemaQuest Pharmaceuticals Business Overview and Its Total Revenue
13.7.3 HemaQuest Pharmaceuticals Hemoglobinopathy Drugs Introduction
13.7.4 HemaQuest Pharmaceuticals Revenue in Hemoglobinopathy Drugs Business (2015-2020)
13.7.5 HemaQuest Pharmaceuticals Recent Development
13.8 Eli Lilly and Company
13.8.1 Eli Lilly and Company Company Details
13.8.2 Eli Lilly and Company Business Overview and Its Total Revenue
13.8.3 Eli Lilly and Company Hemoglobinopathy Drugs Introduction
13.8.4 Eli Lilly and Company Revenue in Hemoglobinopathy Drugs Business (2015-2020)
13.8.5 Eli Lilly and Company Recent Development
13.9 Celgene
13.9.1 Celgene Company Details
13.9.2 Celgene Business Overview and Its Total Revenue
13.9.3 Celgene Hemoglobinopathy Drugs Introduction
13.9.4 Celgene Revenue in Hemoglobinopathy Drugs Business (2015-2020)
13.9.5 Celgene Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Hemoglobinopathy Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Hemoglobinopathy Drugs Revenue
Table 3. Ranking of Global Top Hemoglobinopathy Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hemoglobinopathy Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hydroxyurea
Table 6. Key Players of Glutamine
Table 7. Key Players of Zynteglo
Table 8. Key Players of Other
Table 9. COVID-19 Impact Global Market: (Four Hemoglobinopathy Drugs Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Hemoglobinopathy Drugs Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Hemoglobinopathy Drugs Players to Combat Covid-19 Impact
Table 14. Global Hemoglobinopathy Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Hemoglobinopathy Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Hemoglobinopathy Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Hemoglobinopathy Drugs Market Share by Regions (2015-2020)
Table 18. Global Hemoglobinopathy Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Hemoglobinopathy Drugs Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Hemoglobinopathy Drugs Market Growth Strategy
Table 24. Main Points Interviewed from Key Hemoglobinopathy Drugs Players
Table 25. Global Hemoglobinopathy Drugs Revenue by Players (2015-2020) (Million US$)
Table 26. Global Hemoglobinopathy Drugs Market Share by Players (2015-2020)
Table 27. Global Top Hemoglobinopathy Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemoglobinopathy Drugs as of 2019)
Table 28. Global Hemoglobinopathy Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Hemoglobinopathy Drugs Product Solution and Service
Table 31. Date of Enter into Hemoglobinopathy Drugs Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Hemoglobinopathy Drugs Market Size by Type (2015-2020) (Million US$)
Table 34. Global Hemoglobinopathy Drugs Market Size Share by Type (2015-2020)
Table 35. Global Hemoglobinopathy Drugs Revenue Market Share by Type (2021-2026)
Table 36. Global Hemoglobinopathy Drugs Market Size Share by Application (2015-2020)
Table 37. Global Hemoglobinopathy Drugs Market Size by Application (2015-2020) (Million US$)
Table 38. Global Hemoglobinopathy Drugs Market Size Share by Application (2021-2026)
Table 39. North America Key Players Hemoglobinopathy Drugs Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Hemoglobinopathy Drugs Market Share (2019-2020)
Table 41. North America Hemoglobinopathy Drugs Market Size by Type (2015-2020) (Million US$)
Table 42. North America Hemoglobinopathy Drugs Market Share by Type (2015-2020)
Table 43. North America Hemoglobinopathy Drugs Market Size by Application (2015-2020) (Million US$)
Table 44. North America Hemoglobinopathy Drugs Market Share by Application (2015-2020)
Table 45. Europe Key Players Hemoglobinopathy Drugs Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Hemoglobinopathy Drugs Market Share (2019-2020)
Table 47. Europe Hemoglobinopathy Drugs Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Hemoglobinopathy Drugs Market Share by Type (2015-2020)
Table 49. Europe Hemoglobinopathy Drugs Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Hemoglobinopathy Drugs Market Share by Application (2015-2020)
Table 51. China Key Players Hemoglobinopathy Drugs Revenue (2019-2020) (Million US$)
Table 52. China Key Players Hemoglobinopathy Drugs Market Share (2019-2020)
Table 53. China Hemoglobinopathy Drugs Market Size by Type (2015-2020) (Million US$)
Table 54. China Hemoglobinopathy Drugs Market Share by Type (2015-2020)
Table 55. China Hemoglobinopathy Drugs Market Size by Application (2015-2020) (Million US$)
Table 56. China Hemoglobinopathy Drugs Market Share by Application (2015-2020)
Table 57. Japan Key Players Hemoglobinopathy Drugs Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Hemoglobinopathy Drugs Market Share (2019-2020)
Table 59. Japan Hemoglobinopathy Drugs Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Hemoglobinopathy Drugs Market Share by Type (2015-2020)
Table 61. Japan Hemoglobinopathy Drugs Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Hemoglobinopathy Drugs Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Hemoglobinopathy Drugs Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Hemoglobinopathy Drugs Market Share (2019-2020)
Table 65. Southeast Asia Hemoglobinopathy Drugs Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Hemoglobinopathy Drugs Market Share by Type (2015-2020)
Table 67. Southeast Asia Hemoglobinopathy Drugs Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Hemoglobinopathy Drugs Market Share by Application (2015-2020)
Table 69. India Key Players Hemoglobinopathy Drugs Revenue (2019-2020) (Million US$)
Table 70. India Key Players Hemoglobinopathy Drugs Market Share (2019-2020)
Table 71. India Hemoglobinopathy Drugs Market Size by Type (2015-2020) (Million US$)
Table 72. India Hemoglobinopathy Drugs Market Share by Type (2015-2020)
Table 73. India Hemoglobinopathy Drugs Market Size by Application (2015-2020) (Million US$)
Table 74. India Hemoglobinopathy Drugs Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Hemoglobinopathy Drugs Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Hemoglobinopathy Drugs Market Share (2019-2020)
Table 77. Central & South America Hemoglobinopathy Drugs Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Hemoglobinopathy Drugs Market Share by Type (2015-2020)
Table 79. Central & South America Hemoglobinopathy Drugs Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Hemoglobinopathy Drugs Market Share by Application (2015-2020)
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Product
Table 84. Novartis Revenue in Hemoglobinopathy Drugs Business (2015-2020) (Million US$)
Table 85. Novartis Recent Development
Table 86. AstraZeneca Company Details
Table 87. AstraZeneca Business Overview
Table 88. AstraZeneca Product
Table 89. AstraZeneca Revenue in Hemoglobinopathy Drugs Business (2015-2020) (Million US$)
Table 90. AstraZeneca Recent Development
Table 91. Bluebird Company Details
Table 92. Bluebird Business Overview
Table 93. Bluebird Product
Table 94. Bluebird Revenue in Hemoglobinopathy Drugs Business (2015-2020) (Million US$)
Table 95. Bluebird Recent Development
Table 96. Bristol-Myers Squibb Company Details
Table 97. Bristol-Myers Squibb Business Overview
Table 98. Bristol-Myers Squibb Product
Table 99. Bristol-Myers Squibb Revenue in Hemoglobinopathy Drugs Business (2015-2020) (Million US$)
Table 100. Bristol-Myers Squibb Recent Development
Table 101. Emmaus Medical Company Details
Table 102. Emmaus Medical Business Overview
Table 103. Emmaus Medical Product
Table 104. Emmaus Medical Revenue in Hemoglobinopathy Drugs Business (2015-2020) (Million US$)
Table 105. Emmaus Medical Recent Development
Table 106. Acceleron Pharma Company Details
Table 107. Acceleron Pharma Business Overview
Table 108. Acceleron Pharma Product
Table 109. Acceleron Pharma Revenue in Hemoglobinopathy Drugs Business (2015-2020) (Million US$)
Table 110. Acceleron Pharma Recent Development
Table 111. HemaQuest Pharmaceuticals Company Details
Table 112. HemaQuest Pharmaceuticals Business Overview
Table 113. HemaQuest Pharmaceuticals Product
Table 114. HemaQuest Pharmaceuticals Revenue in Hemoglobinopathy Drugs Business (2015-2020) (Million US$)
Table 115. HemaQuest Pharmaceuticals Recent Development
Table 116. Eli Lilly and Company Business Overview
Table 117. Eli Lilly and Company Product
Table 118. Eli Lilly and Company Company Details
Table 119. Eli Lilly and Company Revenue in Hemoglobinopathy Drugs Business (2015-2020) (Million US$)
Table 120. Eli Lilly and Company Recent Development
Table 121. Celgene Company Details
Table 122. Celgene Business Overview
Table 123. Celgene Product
Table 124. Celgene Revenue in Hemoglobinopathy Drugs Business (2015-2020) (Million US$)
Table 125. Celgene Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 1. Hemoglobinopathy Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Hemoglobinopathy Drugs Revenue
Table 3. Ranking of Global Top Hemoglobinopathy Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hemoglobinopathy Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hydroxyurea
Table 6. Key Players of Glutamine
Table 7. Key Players of Zynteglo
Table 8. Key Players of Other
Table 9. COVID-19 Impact Global Market: (Four Hemoglobinopathy Drugs Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Hemoglobinopathy Drugs Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Hemoglobinopathy Drugs Players to Combat Covid-19 Impact
Table 14. Global Hemoglobinopathy Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Hemoglobinopathy Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Hemoglobinopathy Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Hemoglobinopathy Drugs Market Share by Regions (2015-2020)
Table 18. Global Hemoglobinopathy Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Hemoglobinopathy Drugs Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Hemoglobinopathy Drugs Market Growth Strategy
Table 24. Main Points Interviewed from Key Hemoglobinopathy Drugs Players
Table 25. Global Hemoglobinopathy Drugs Revenue by Players (2015-2020) (Million US$)
Table 26. Global Hemoglobinopathy Drugs Market Share by Players (2015-2020)
Table 27. Global Top Hemoglobinopathy Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemoglobinopathy Drugs as of 2019)
Table 28. Global Hemoglobinopathy Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Hemoglobinopathy Drugs Product Solution and Service
Table 31. Date of Enter into Hemoglobinopathy Drugs Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Hemoglobinopathy Drugs Market Size by Type (2015-2020) (Million US$)
Table 34. Global Hemoglobinopathy Drugs Market Size Share by Type (2015-2020)
Table 35. Global Hemoglobinopathy Drugs Revenue Market Share by Type (2021-2026)
Table 36. Global Hemoglobinopathy Drugs Market Size Share by Application (2015-2020)
Table 37. Global Hemoglobinopathy Drugs Market Size by Application (2015-2020) (Million US$)
Table 38. Global Hemoglobinopathy Drugs Market Size Share by Application (2021-2026)
Table 39. North America Key Players Hemoglobinopathy Drugs Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Hemoglobinopathy Drugs Market Share (2019-2020)
Table 41. North America Hemoglobinopathy Drugs Market Size by Type (2015-2020) (Million US$)
Table 42. North America Hemoglobinopathy Drugs Market Share by Type (2015-2020)
Table 43. North America Hemoglobinopathy Drugs Market Size by Application (2015-2020) (Million US$)
Table 44. North America Hemoglobinopathy Drugs Market Share by Application (2015-2020)
Table 45. Europe Key Players Hemoglobinopathy Drugs Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Hemoglobinopathy Drugs Market Share (2019-2020)
Table 47. Europe Hemoglobinopathy Drugs Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Hemoglobinopathy Drugs Market Share by Type (2015-2020)
Table 49. Europe Hemoglobinopathy Drugs Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Hemoglobinopathy Drugs Market Share by Application (2015-2020)
Table 51. China Key Players Hemoglobinopathy Drugs Revenue (2019-2020) (Million US$)
Table 52. China Key Players Hemoglobinopathy Drugs Market Share (2019-2020)
Table 53. China Hemoglobinopathy Drugs Market Size by Type (2015-2020) (Million US$)
Table 54. China Hemoglobinopathy Drugs Market Share by Type (2015-2020)
Table 55. China Hemoglobinopathy Drugs Market Size by Application (2015-2020) (Million US$)
Table 56. China Hemoglobinopathy Drugs Market Share by Application (2015-2020)
Table 57. Japan Key Players Hemoglobinopathy Drugs Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Hemoglobinopathy Drugs Market Share (2019-2020)
Table 59. Japan Hemoglobinopathy Drugs Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Hemoglobinopathy Drugs Market Share by Type (2015-2020)
Table 61. Japan Hemoglobinopathy Drugs Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Hemoglobinopathy Drugs Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Hemoglobinopathy Drugs Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Hemoglobinopathy Drugs Market Share (2019-2020)
Table 65. Southeast Asia Hemoglobinopathy Drugs Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Hemoglobinopathy Drugs Market Share by Type (2015-2020)
Table 67. Southeast Asia Hemoglobinopathy Drugs Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Hemoglobinopathy Drugs Market Share by Application (2015-2020)
Table 69. India Key Players Hemoglobinopathy Drugs Revenue (2019-2020) (Million US$)
Table 70. India Key Players Hemoglobinopathy Drugs Market Share (2019-2020)
Table 71. India Hemoglobinopathy Drugs Market Size by Type (2015-2020) (Million US$)
Table 72. India Hemoglobinopathy Drugs Market Share by Type (2015-2020)
Table 73. India Hemoglobinopathy Drugs Market Size by Application (2015-2020) (Million US$)
Table 74. India Hemoglobinopathy Drugs Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Hemoglobinopathy Drugs Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Hemoglobinopathy Drugs Market Share (2019-2020)
Table 77. Central & South America Hemoglobinopathy Drugs Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Hemoglobinopathy Drugs Market Share by Type (2015-2020)
Table 79. Central & South America Hemoglobinopathy Drugs Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Hemoglobinopathy Drugs Market Share by Application (2015-2020)
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Product
Table 84. Novartis Revenue in Hemoglobinopathy Drugs Business (2015-2020) (Million US$)
Table 85. Novartis Recent Development
Table 86. AstraZeneca Company Details
Table 87. AstraZeneca Business Overview
Table 88. AstraZeneca Product
Table 89. AstraZeneca Revenue in Hemoglobinopathy Drugs Business (2015-2020) (Million US$)
Table 90. AstraZeneca Recent Development
Table 91. Bluebird Company Details
Table 92. Bluebird Business Overview
Table 93. Bluebird Product
Table 94. Bluebird Revenue in Hemoglobinopathy Drugs Business (2015-2020) (Million US$)
Table 95. Bluebird Recent Development
Table 96. Bristol-Myers Squibb Company Details
Table 97. Bristol-Myers Squibb Business Overview
Table 98. Bristol-Myers Squibb Product
Table 99. Bristol-Myers Squibb Revenue in Hemoglobinopathy Drugs Business (2015-2020) (Million US$)
Table 100. Bristol-Myers Squibb Recent Development
Table 101. Emmaus Medical Company Details
Table 102. Emmaus Medical Business Overview
Table 103. Emmaus Medical Product
Table 104. Emmaus Medical Revenue in Hemoglobinopathy Drugs Business (2015-2020) (Million US$)
Table 105. Emmaus Medical Recent Development
Table 106. Acceleron Pharma Company Details
Table 107. Acceleron Pharma Business Overview
Table 108. Acceleron Pharma Product
Table 109. Acceleron Pharma Revenue in Hemoglobinopathy Drugs Business (2015-2020) (Million US$)
Table 110. Acceleron Pharma Recent Development
Table 111. HemaQuest Pharmaceuticals Company Details
Table 112. HemaQuest Pharmaceuticals Business Overview
Table 113. HemaQuest Pharmaceuticals Product
Table 114. HemaQuest Pharmaceuticals Revenue in Hemoglobinopathy Drugs Business (2015-2020) (Million US$)
Table 115. HemaQuest Pharmaceuticals Recent Development
Table 116. Eli Lilly and Company Business Overview
Table 117. Eli Lilly and Company Product
Table 118. Eli Lilly and Company Company Details
Table 119. Eli Lilly and Company Revenue in Hemoglobinopathy Drugs Business (2015-2020) (Million US$)
Table 120. Eli Lilly and Company Recent Development
Table 121. Celgene Company Details
Table 122. Celgene Business Overview
Table 123. Celgene Product
Table 124. Celgene Revenue in Hemoglobinopathy Drugs Business (2015-2020) (Million US$)
Table 125. Celgene Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Hemoglobinopathy Drugs Market Share by Type: 2020 VS 2026
Figure 2. Hydroxyurea Features
Figure 3. Glutamine Features
Figure 4. Zynteglo Features
Figure 5. Other Features
Figure 6. Global Hemoglobinopathy Drugs Market Share by Application: 2020 VS 2026
Figure 7. Sickle Cell Diseases Case Studies
Figure 8. Thalassemia Case Studies
Figure 9. Hemoglobinopathy Drugs Report Years Considered
Figure 10. Global Hemoglobinopathy Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Hemoglobinopathy Drugs Market Share by Regions: 2020 VS 2026
Figure 12. Global Hemoglobinopathy Drugs Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Hemoglobinopathy Drugs Market Share by Players in 2019
Figure 15. Global Top Hemoglobinopathy Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemoglobinopathy Drugs as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Hemoglobinopathy Drugs Revenue in 2019
Figure 17. North America Hemoglobinopathy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Hemoglobinopathy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Hemoglobinopathy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Hemoglobinopathy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Hemoglobinopathy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Hemoglobinopathy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Hemoglobinopathy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Novartis Revenue Growth Rate in Hemoglobinopathy Drugs Business (2015-2020)
Figure 26. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. AstraZeneca Revenue Growth Rate in Hemoglobinopathy Drugs Business (2015-2020)
Figure 28. Bluebird Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Bluebird Revenue Growth Rate in Hemoglobinopathy Drugs Business (2015-2020)
Figure 30. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Bristol-Myers Squibb Revenue Growth Rate in Hemoglobinopathy Drugs Business (2015-2020)
Figure 32. Emmaus Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Emmaus Medical Revenue Growth Rate in Hemoglobinopathy Drugs Business (2015-2020)
Figure 34. Acceleron Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Acceleron Pharma Revenue Growth Rate in Hemoglobinopathy Drugs Business (2015-2020)
Figure 36. HemaQuest Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. HemaQuest Pharmaceuticals Revenue Growth Rate in Hemoglobinopathy Drugs Business (2015-2020)
Figure 38. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Eli Lilly and Company Revenue Growth Rate in Hemoglobinopathy Drugs Business (2015-2020)
Figure 40. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Celgene Revenue Growth Rate in Hemoglobinopathy Drugs Business (2015-2020)
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed
Figure 1. Global Hemoglobinopathy Drugs Market Share by Type: 2020 VS 2026
Figure 2. Hydroxyurea Features
Figure 3. Glutamine Features
Figure 4. Zynteglo Features
Figure 5. Other Features
Figure 6. Global Hemoglobinopathy Drugs Market Share by Application: 2020 VS 2026
Figure 7. Sickle Cell Diseases Case Studies
Figure 8. Thalassemia Case Studies
Figure 9. Hemoglobinopathy Drugs Report Years Considered
Figure 10. Global Hemoglobinopathy Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Hemoglobinopathy Drugs Market Share by Regions: 2020 VS 2026
Figure 12. Global Hemoglobinopathy Drugs Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Hemoglobinopathy Drugs Market Share by Players in 2019
Figure 15. Global Top Hemoglobinopathy Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemoglobinopathy Drugs as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Hemoglobinopathy Drugs Revenue in 2019
Figure 17. North America Hemoglobinopathy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Hemoglobinopathy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Hemoglobinopathy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Hemoglobinopathy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Hemoglobinopathy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Hemoglobinopathy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Hemoglobinopathy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Novartis Revenue Growth Rate in Hemoglobinopathy Drugs Business (2015-2020)
Figure 26. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. AstraZeneca Revenue Growth Rate in Hemoglobinopathy Drugs Business (2015-2020)
Figure 28. Bluebird Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Bluebird Revenue Growth Rate in Hemoglobinopathy Drugs Business (2015-2020)
Figure 30. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Bristol-Myers Squibb Revenue Growth Rate in Hemoglobinopathy Drugs Business (2015-2020)
Figure 32. Emmaus Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Emmaus Medical Revenue Growth Rate in Hemoglobinopathy Drugs Business (2015-2020)
Figure 34. Acceleron Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Acceleron Pharma Revenue Growth Rate in Hemoglobinopathy Drugs Business (2015-2020)
Figure 36. HemaQuest Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. HemaQuest Pharmaceuticals Revenue Growth Rate in Hemoglobinopathy Drugs Business (2015-2020)
Figure 38. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Eli Lilly and Company Revenue Growth Rate in Hemoglobinopathy Drugs Business (2015-2020)
Figure 40. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Celgene Revenue Growth Rate in Hemoglobinopathy Drugs Business (2015-2020)
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed